Tuesday, December 13, 2022
This conference has already taken place.
Description
It is understood that all APP's have knowledge of billing and documentation guidelines but may not complete these to the fullest. In addition, a recognized educational gap for advanced practice providers involves new heart failure guidelines, immunosuppression and immunology, and improving communication strategies in the cardiovascular field. During the sessions planned for the 2022-23 series discussions will also include utilization of a wearable defibrillator; long-term care of ventilated patients; and ECMO management.
Dates and Times
Start: 12/13/2022 12:00 PM
End: 12/13/2022 1:00 PM
Objectives
At the conclusion of this CME activity participants will be able to:
1. Discuss the expanded use of sodium-glucose co-transporter 2 inhibitors (SGLT2i);
2. Review the components of transplant immunology;
3. Evaluate immunosuppression regimens and their place in therapy;
4. Evaluate communication strategies between the healthcare team and patients.
Agenda
Pricing
| Tier | Price |
|---|---|
| Nurse/Nurse Practitioner | $0.00 |
| Physician Assistant | $0.00 |
| Allied Health Professional | $0.00 |
Speakers
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.